Federal Register - January 26, 2021
Version en texte Qu'est-ce que c'est?Dateas est un site Web indépendant, non affilié à un organisme gouvernemental. La source des documents PDF que nous publions est l'agence officielle indiquée dans chacun d'eux. Les versions en texte sont des transcriptions non officielles que nous faisons pour fournir de meilleurs outils d'accès et de recherche d'informations, mais peuvent contenir des erreurs ou peuvent ne pas être complètes.
Source: Federal Register
7059
Rules and Regulations
Federal Register Vol. 86, No. 15
Tuesday, January 26, 2021
This section of the FEDERAL REGISTER
contains regulatory documents having general applicability and legal effect, most of which are keyed to and codified in the Code of Federal Regulations, which is published under 50 titles pursuant to 44 U.S.C. 1510.
The Code of Federal Regulations is sold by the Superintendent of Documents.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
42 CFR Part 51c RIN 0906AB25
Implementation of Executive Order on Access to Affordable Life-Saving Medications Health Resources and Services Administration HRSA, Health and Human Services HHS.
ACTION: Final rule; delay of effective date.
AGENCY:
In accordance with the memorandum of January 20, 2021, from the Assistant to the President and Chief of Staff, entitled Regulatory Freeze Pending Review, this action
SUMMARY:
VerDate Sep<11>2014
16:40 Jan 25, 2021
Jkt 253001
temporarily delays for 60 days from the date of the memorandum the effective date of the final rule titled Implementation of Executive Order on Access to Affordable Life-saving Medications, published in the December 23, 2020, Federal Register.
This document announces that the effective date is delayed until March 22, 2021, the first business day after 60 days from the date of the memorandum.
DATES: The effective date of the final rule published in the December 23, 2020, Federal Register 85 FR 83822, is delayed from January 22, 2021, to March 22, 2021.
FOR FURTHER INFORMATION CONTACT:
Jennifer Joseph, Director, Office of Policy and Program Development, Bureau of Primary Health Care, HRSA, 5600 Fishers Lane, Rockville, MD
20857; by email at jjoseph@hrsa.gov;
telephone: 3015944300; fax: 301
5944997.
SUPPLEMENTARY INFORMATION: The January 20, 2021 memorandum from the Assistant to the President and Chief of Staff, entitled Regulatory Freeze Pending Review, instructed Federal agencies to delay the effective date of
PO 00000
Frm 00001
Fmt 4700
Sfmt 9990
rules published in the Federal Register, but which have not yet taken effect, for a period of 60 days from the date of the memorandum. This final rule will apply to all health centers receiving section 330e grant funds that participate in the 340B Drug Pricing Program 340B
Program, 42 U.S.C. 254b and 256b, and requires such entities to make insulin and injectable epinephrine available to health center patients identified as low-income or below the same price the health center paid through the 340B Program. The effective date of that rule, which would have been January 22, 2021, is now March 22, 2021. The temporary delay in the effective date of this final rule is necessary to give Department officials the opportunity for further review and consideration of new regulations, consistent with the memorandum of January 20, 2021, from the Assistant to the President and Chief of Staff, entitled Regulatory Freeze Pending Review.
Norris Cochran, Acting Secretary, Department of Health and Human Services.
FR Doc. 202101629 Filed 12121; 4:15 pm BILLING CODE 416515P
E:FRFM26JAR1.SGM
26JAR1
